{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:58:54Z","timestamp":1766908734641,"version":"3.48.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,27]]},"DOI":"10.7759\/cureus.100230","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:53:50Z","timestamp":1766908430000},"source":"Crossref","is-referenced-by-count":0,"title":["Glucocorticoid-Free Induction Therapy With Hydroxychloroquine and Anifrolumab in Systemic Lupus Erythematosus: A Case Report"],"prefix":"10.7759","author":[{"given":"Mitsuki","family":"Tezuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimoyama","family":"Shuhei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanari","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis A","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al.. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024, 83:15-29. 10.1136\/ard-2023-224762","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225369","article-title":"Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study","volume":"83","author":"Katsumata Y","year":"2024","unstructured":"Katsumata Y, Inoue E, Harigai M, et al.. Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study. Ann Rheum Dis. 2024, 83:998-1005. 10.1136\/ard-2023-225369","journal-title":"Ann Rheum Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead348","article-title":"Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality - a national cohort study","volume":"63","author":"Frodlund M","year":"2024","unstructured":"Frodlund M, J\u00f6nsen A, Remkus L, Telg G, S\u00f6derdahl F, Leonard D. Glucocorticoid treatment in SLE is associated with infections, comorbidities and mortality - a national cohort study. Rheumatology (Oxford). 2024, 63:1104-12. 10.1093\/rheumatology\/kead348","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven RF","year":"2021","unstructured":"van Vollenhoven RF, Bertsias G, Doria A, et al.. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med. 2021, 8:000538. 10.1136\/lupus-2021-000538","journal-title":"Lupus Sci Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier E","year":"2020","unstructured":"Schrezenmeier E, D\u00f6rner T. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020, 16:155-66. 10.1038\/s41584-020-0372-x","journal-title":"Nat Rev Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58391-2","article-title":"Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus","volume":"14","author":"Liu PC","year":"2024","unstructured":"Liu PC, Luo SL, Lv MN, Wang Y, Li JB, Yu SJ, Wu R. Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus. Sci Rep. 2024, 14:7674. 10.1038\/s41598-024-58391-2","journal-title":"Sci Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand EF","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, et al.. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020, 382:211-21. 10.1056\/NEJMoa1912196","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/421862-glucocorticoid-free-induction-therapy-with-hydroxychloroquine-and-anifrolumab-in-systemic-lupus-erythematosus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T07:53:52Z","timestamp":1766908432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/421862-glucocorticoid-free-induction-therapy-with-hydroxychloroquine-and-anifrolumab-in-systemic-lupus-erythematosus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.100230","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}